-
Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme
van der Helm, L. H., Alhan, C., Wijermans, P. W., van Marwijk Kooy, M., Schaafsma, R., Biemond, B. J., Beeker, A., Hoogendoorn, M., van Rees, B. P., de Weerdt, O., Wegman, J., Libourel, W. J., Luykx-de Bakker, S. A., Minnema, M. C., Brouwer, R. E., Croon-de Boer, F., Eefting, M., Jie, K.-S. G., van de Loosdrecht, A. A. & Koedam, J. & 4 others, , 2011, In: British journal of haematology. 155, 5, p. 599-606Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
